GeoVax’s Unique Multi-Antigenic Vaccine Approach Designed to Provide Stronger, Broader Protection Against Malaria Atlanta, GA, April 26, 2022 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (NASDAQ: GOVX), a biotechnology company developing human vaccines and immunotherapies against infectious diseases … Continue reading GeoVax (NASDAQ: GOVX) Announces Issuance of Malaria Vaccine Patent